SCHEMBL8876597

SCHEMBL8876597

C=CS(=O)(=O)NCc1cccc2c(=O)c(C)c(-c3ccccc3)oc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.42
MAPT P10636 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
NPSR1 Q6W5P4 3/20 0.42
GAA P10253 1/20 0.42
ALDH1A1 P00352 7/20 0.42
CYP3A4 P08684 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HTR1A P08908 2/20 0.40
ADRA1A P35348 2/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
ADRA2A P08913 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CYP2D6 P10635 1/20 0.40
CHRM1 P11229 1/20 0.40
ACHE P22303 1/20 0.40
SLC6A2 P23975 1/20 0.40
PDE4A P27815 1/20 0.40
OPRM1 P35372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8875855 0.81 LMNA (0.48) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8877052 0.81 LMNA (0.42) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8876534 0.80 AURKA (0.49) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL5118184 0.80 LMNA (0.54) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL14266220 0.78 LMNA (0.55) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8875487 0.77 LMNA (0.47) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8875991 0.76 LMNA (0.47) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL5116298 0.76 LMNA (0.50) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8874632 0.76 LMNA (0.50) LMNAMAPTSMN1; SMN2NPSR1GAA
SCHEMBL8877218 0.75 LMNA (0.47) LMNAMAPTSMN1; SMN2NPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5605896-A Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1997-02-25 US disclosed
US-5474994-A Treating hypertension, urethral and lower urinary tract contractions RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-12-12 US disclosed
US-5403842-A Adrenergic blocking and antiserotonine agents; urogenital disorders including spasms of the urethral tract and prostrate problems RECORDATI S.A., CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-04-04 US disclosed
WO-1993017007-A1 HETEROBICYCLIC COMPOUNDS RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. (IT) 1993-09-02 WO disclosed
EP-0558245-A1 Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1993-09-01 EP disclosed